Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1985; 78(Suppl 9): 15–17.
PMCID: PMC1289528

Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (423K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alexieva-Figusch J, van Gilse HA, Hop WC, Phoa CH, Blonk-van der Wijst J, Treurniet RE. Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases. Cancer. 1980 Dec 1;46(11):2369–2372. [PubMed]
  • DAO TL, TAN E, BROOKS V. A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma. Cancer. 1961 Nov-Dec;14:1259–1265. [PubMed]
  • Fracchia AA, Randall HT, Farrow JH. The results of adrenalectomy in advanced breast cancer in 500 consecutive patients. Surg Gynecol Obstet. 1967 Oct;125(4):747–756. [PubMed]
  • Fracchia AA, Farrow JH, DePalo AJ, Connolly DP, Huvos AG. Castration for primary inoperable or recurrent breast carcinoma. Surg Gynecol Obstet. 1969 Jun;128(6):1226–1234. [PubMed]
  • Fracchia AA, Farrow JH, Miller TR, Tollefsen RH, Greenberg EJ, Knapper WH. Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast. Surg Gynecol Obstet. 1971 Aug;133(2):241–246. [PubMed]
  • GORDAN GS, GRAHAM WP, 3rd, GOLDMAN L, PAPAC R, SHELINE GE, VAETH J, WITT J. Hormonal treatment of disseminated cancer of the female breast. Calif Med. 1963 Apr;98:189–194. [PMC free article] [PubMed]
  • Ingle JN, Green SJ, Ahmann DL, Edmonson JH, Nichols WC, Frytak S, Rubin J. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure. Cancer Res. 1982 Aug;42(8 Suppl):3461s–3467s. [PubMed]
  • Johnson JR, Priestman TJ, Fotherby K, Kelly KA, Priestman SG. An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer. Br J Cancer. 1984 Sep;50(3):363–366. [PMC free article] [PubMed]
  • LEMON HM. Cortisone-thyroid therapy of metastatic mammary cancer. Ann Intern Med. 1957 Mar;46(3):457–484. [PubMed]
  • Lipton A, Harvey HA, Santen RJ, Boucher A, White D, Bernath A, Dixon R, Richards G, Shafik A. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3434s–3436s. [PubMed]
  • Nemoto T, Patel J, Rosner D, Dao TL. Tamoxifen (Nolvadex) versus adrenalectomy in metastatic breast cancer. Cancer. 1984 Mar 15;53(6):1333–1335. [PubMed]
  • PEARSON OH, RAY BS. Results of hypophysectomy in the treatment of metastatic mammary carcinoma. Cancer. 1959 Jan-Feb;12(1):85–92. [PubMed]
  • Santen RJ, Worgul TJ, Samojlik E, Interrante A, Boucher AE, Lipton A, Harvey HA, White DS, Smart E, Cox C, et al. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med. 1981 Sep 3;305(10):545–551. [PubMed]
  • Smith IE, Harris AL, Morgan M, Ford HT, Gazet JC, Harmer CL, White H, Parsons CA, Villardo A, Walsh G, et al. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) 1981 Nov 28;283(6304):1432–1434. [PMC free article] [PubMed]
  • Smith IE, Harris AL, Stuart-Harris R, Ford HT, Gazet JC, White H, Harmer CL, Carr L, McKinna JA, Morgan M. Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1615–1616. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press